nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—SLC1A1—nephron tubule—kidney cancer	0.00573	0.236	CbGeAlD
Pregabalin—SLC1A1—renal system—kidney cancer	0.00521	0.215	CbGeAlD
Pregabalin—SLC1A1—kidney—kidney cancer	0.00504	0.208	CbGeAlD
Pregabalin—SLC1A1—cortex of kidney—kidney cancer	0.00491	0.202	CbGeAlD
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.00341	0.0442	CbGpPWpGaD
Pregabalin—CACNA2D2—cardiac atrium—kidney cancer	0.00337	0.139	CbGeAlD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—RYR1—kidney cancer	0.00334	0.0433	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA1—kidney cancer	0.00308	0.0399	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—GJB1—kidney cancer	0.00221	0.0287	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—ITPR2—kidney cancer	0.00219	0.0283	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00201	0.026	CbGpPWpGaD
Pregabalin—CACNA1A—Type II diabetes mellitus—MTOR—kidney cancer	0.00197	0.0255	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—ITPR2—kidney cancer	0.00183	0.0238	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—ITPR2—kidney cancer	0.00172	0.0223	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA1—kidney cancer	0.00172	0.0222	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.0017	0.022	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—SLC2A1—kidney cancer	0.00166	0.0215	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00151	0.0195	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—ITPR2—kidney cancer	0.00144	0.0187	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—SLC2A1—kidney cancer	0.00139	0.018	CbGpPWpGaD
Pregabalin—CACNA1A—Type II diabetes mellitus—MAPK1—kidney cancer	0.00138	0.0179	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—KCNMA1—kidney cancer	0.00133	0.0173	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—SLC2A1—kidney cancer	0.0013	0.0169	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	0.00129	0.0167	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.00129	0.0167	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00112	0.0145	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—SLC2A1—kidney cancer	0.00109	0.0142	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—kidney cancer	0.000995	0.0129	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—ACHE—kidney cancer	0.000985	0.0128	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—KCNMA1—kidney cancer	0.000963	0.0125	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—ACHE—kidney cancer	0.00093	0.012	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000897	0.0116	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000866	0.0112	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000864	0.0112	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000864	0.0112	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000864	0.0112	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BCHE—kidney cancer	0.000858	0.0111	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00081	0.0105	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—KCNMA1—kidney cancer	0.000807	0.0105	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000779	0.0101	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—ACHE—kidney cancer	0.000712	0.00923	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000679	0.00879	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BCHE—kidney cancer	0.000621	0.00804	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—ACHE—kidney cancer	0.000597	0.00773	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000572	0.00741	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ACY1—kidney cancer	0.000557	0.00722	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—kidney cancer	0.000555	0.00718	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BCHE—kidney cancer	0.00052	0.00674	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000477	0.00618	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PDHB—kidney cancer	0.000474	0.00614	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ACY1—kidney cancer	0.000467	0.00605	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000456	0.00591	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CCBL1—kidney cancer	0.000445	0.00577	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00044	0.0057	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BRAF—kidney cancer	0.000438	0.00567	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000413	0.00535	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PDHB—kidney cancer	0.000397	0.00514	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GLIPR1—kidney cancer	0.000386	0.005	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPAT—kidney cancer	0.000386	0.005	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CCBL1—kidney cancer	0.000373	0.00484	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—RAF1—kidney cancer	0.000366	0.00474	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—FH—kidney cancer	0.000359	0.00465	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—APRT—kidney cancer	0.000359	0.00465	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000348	0.0045	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000346	0.00449	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000345	0.00447	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GPC3—kidney cancer	0.000338	0.00437	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CA2—kidney cancer	0.000328	0.00425	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000327	0.00424	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GLIPR1—kidney cancer	0.000324	0.00419	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPAT—kidney cancer	0.000324	0.00419	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALAD—kidney cancer	0.00032	0.00415	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BRAF—kidney cancer	0.000317	0.0041	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ST3GAL2—kidney cancer	0.000312	0.00405	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALDH1A1—kidney cancer	0.000305	0.00395	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—APRT—kidney cancer	0.000301	0.0039	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—FH—kidney cancer	0.000301	0.0039	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PGK1—kidney cancer	0.000293	0.00379	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC5A3—kidney cancer	0.000293	0.00379	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000289	0.00375	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—LDHB—kidney cancer	0.000287	0.00372	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GPC3—kidney cancer	0.000283	0.00366	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CA2—kidney cancer	0.000275	0.00356	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALAD—kidney cancer	0.000268	0.00347	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BRAF—kidney cancer	0.000265	0.00344	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—RAF1—kidney cancer	0.000264	0.00343	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ST3GAL2—kidney cancer	0.000262	0.00339	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALDH1A1—kidney cancer	0.000256	0.00331	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—MAPK1—kidney cancer	0.000251	0.00325	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CA9—kidney cancer	0.000249	0.00322	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PGK1—kidney cancer	0.000245	0.00318	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC5A3—kidney cancer	0.000245	0.00318	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—LDHB—kidney cancer	0.000241	0.00312	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000237	0.00307	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—RAF1—kidney cancer	0.000222	0.00287	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CRABP1—kidney cancer	0.000212	0.00274	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CA9—kidney cancer	0.000209	0.0027	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000198	0.00257	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ITPR2—kidney cancer	0.000197	0.00255	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000197	0.00255	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—MAPK1—kidney cancer	0.000181	0.00235	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTT1—kidney cancer	0.000179	0.00232	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ACHE—kidney cancer	0.000179	0.00232	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CRABP1—kidney cancer	0.000177	0.0023	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SCARB1—kidney cancer	0.00017	0.0022	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS1—kidney cancer	0.000168	0.00218	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ITPR2—kidney cancer	0.000165	0.00214	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PSMD7—kidney cancer	0.000165	0.00214	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—BCHE—kidney cancer	0.000156	0.00202	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC5A5—kidney cancer	0.000154	0.002	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—MAPK1—kidney cancer	0.000152	0.00197	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ACHE—kidney cancer	0.00015	0.00195	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTT1—kidney cancer	0.00015	0.00195	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC2A1—kidney cancer	0.000149	0.00193	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SCARB1—kidney cancer	0.000142	0.00184	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS1—kidney cancer	0.000141	0.00182	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PSMD7—kidney cancer	0.000138	0.00179	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—BCHE—kidney cancer	0.000131	0.0017	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC5A5—kidney cancer	0.000129	0.00168	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC2A1—kidney cancer	0.000125	0.00162	CbGpPWpGaD
Pregabalin—Dysgeusia—Capecitabine—kidney cancer	0.000125	0.000139	CcSEcCtD
Pregabalin—Dizziness—Sunitinib—kidney cancer	0.000124	0.000139	CcSEcCtD
Pregabalin—Feeling abnormal—Gemcitabine—kidney cancer	0.000124	0.000139	CcSEcCtD
Pregabalin—Shock—Paclitaxel—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—Vomiting—Sorafenib—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GSTP1—kidney cancer	0.000124	0.00161	CbGpPWpGaD
Pregabalin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—Nervous system disorder—Paclitaxel—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—Hypokalaemia—Doxorubicin—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000124	0.000138	CcSEcCtD
Pregabalin—Tachycardia—Paclitaxel—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Rash—Sorafenib—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Dermatitis—Sorafenib—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Back pain—Capecitabine—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Breast disorder—Doxorubicin—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Skin disorder—Paclitaxel—kidney cancer	0.000123	0.000137	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000123	0.000136	CcSEcCtD
Pregabalin—Headache—Sorafenib—kidney cancer	0.000123	0.000136	CcSEcCtD
Pregabalin—Muscle spasms—Capecitabine—kidney cancer	0.000122	0.000136	CcSEcCtD
Pregabalin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000122	0.000136	CcSEcCtD
Pregabalin—Diarrhoea—Dactinomycin—kidney cancer	0.000122	0.000136	CcSEcCtD
Pregabalin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000122	0.000135	CcSEcCtD
Pregabalin—Anorexia—Paclitaxel—kidney cancer	0.000121	0.000134	CcSEcCtD
Pregabalin—Gastritis—Doxorubicin—kidney cancer	0.00012	0.000134	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00012	0.000134	CcSEcCtD
Pregabalin—Muscular weakness—Doxorubicin—kidney cancer	0.00012	0.000134	CcSEcCtD
Pregabalin—Vision blurred—Capecitabine—kidney cancer	0.00012	0.000133	CcSEcCtD
Pregabalin—Vomiting—Sunitinib—kidney cancer	0.00012	0.000133	CcSEcCtD
Pregabalin—Body temperature increased—Gemcitabine—kidney cancer	0.000119	0.000133	CcSEcCtD
Pregabalin—Tremor—Capecitabine—kidney cancer	0.000119	0.000133	CcSEcCtD
Pregabalin—Rash—Sunitinib—kidney cancer	0.000119	0.000132	CcSEcCtD
Pregabalin—Dermatitis—Sunitinib—kidney cancer	0.000119	0.000132	CcSEcCtD
Pregabalin—Abdominal distension—Doxorubicin—kidney cancer	0.000118	0.000132	CcSEcCtD
Pregabalin—Hypotension—Paclitaxel—kidney cancer	0.000118	0.000132	CcSEcCtD
Pregabalin—Ill-defined disorder—Capecitabine—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—Headache—Sunitinib—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—ABCB1—kidney cancer	0.000118	0.00152	CbGpPWpGaD
Pregabalin—Dysphagia—Doxorubicin—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—Influenza—Doxorubicin—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—Asthma—Doxorubicin—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—Anaemia—Capecitabine—kidney cancer	0.000118	0.000131	CcSEcCtD
Pregabalin—Hypersensitivity—Vincristine—kidney cancer	0.000117	0.000131	CcSEcCtD
Pregabalin—Eosinophilia—Doxorubicin—kidney cancer	0.000116	0.00013	CcSEcCtD
Pregabalin—Nausea—Sorafenib—kidney cancer	0.000116	0.000129	CcSEcCtD
Pregabalin—Pancreatitis—Doxorubicin—kidney cancer	0.000115	0.000128	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000115	0.000128	CcSEcCtD
Pregabalin—Malaise—Capecitabine—kidney cancer	0.000115	0.000128	CcSEcCtD
Pregabalin—Angina pectoris—Doxorubicin—kidney cancer	0.000115	0.000128	CcSEcCtD
Pregabalin—Insomnia—Paclitaxel—kidney cancer	0.000114	0.000127	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GSTM1—kidney cancer	0.000114	0.00148	CbGpPWpGaD
Pregabalin—Vertigo—Capecitabine—kidney cancer	0.000114	0.000127	CcSEcCtD
Pregabalin—Asthenia—Vincristine—kidney cancer	0.000114	0.000127	CcSEcCtD
Pregabalin—Syncope—Capecitabine—kidney cancer	0.000114	0.000127	CcSEcCtD
Pregabalin—Leukopenia—Capecitabine—kidney cancer	0.000114	0.000127	CcSEcCtD
Pregabalin—Paraesthesia—Paclitaxel—kidney cancer	0.000114	0.000126	CcSEcCtD
Pregabalin—Vomiting—Dactinomycin—kidney cancer	0.000113	0.000126	CcSEcCtD
Pregabalin—Bronchitis—Doxorubicin—kidney cancer	0.000113	0.000126	CcSEcCtD
Pregabalin—Dyspnoea—Paclitaxel—kidney cancer	0.000113	0.000125	CcSEcCtD
Pregabalin—Somnolence—Paclitaxel—kidney cancer	0.000112	0.000125	CcSEcCtD
Pregabalin—Palpitations—Capecitabine—kidney cancer	0.000112	0.000125	CcSEcCtD
Pregabalin—Rash—Dactinomycin—kidney cancer	0.000112	0.000125	CcSEcCtD
Pregabalin—Nausea—Sunitinib—kidney cancer	0.000112	0.000124	CcSEcCtD
Pregabalin—Loss of consciousness—Capecitabine—kidney cancer	0.000112	0.000124	CcSEcCtD
Pregabalin—Pancytopenia—Doxorubicin—kidney cancer	0.000112	0.000124	CcSEcCtD
Pregabalin—Cough—Capecitabine—kidney cancer	0.000111	0.000123	CcSEcCtD
Pregabalin—Neutropenia—Doxorubicin—kidney cancer	0.00011	0.000122	CcSEcCtD
Pregabalin—Dysuria—Doxorubicin—kidney cancer	0.00011	0.000122	CcSEcCtD
Pregabalin—Decreased appetite—Paclitaxel—kidney cancer	0.00011	0.000122	CcSEcCtD
Pregabalin—Hypertension—Capecitabine—kidney cancer	0.00011	0.000122	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000109	0.000122	CcSEcCtD
Pregabalin—Fatigue—Paclitaxel—kidney cancer	0.000109	0.000121	CcSEcCtD
Pregabalin—Diarrhoea—Vincristine—kidney cancer	0.000109	0.000121	CcSEcCtD
Pregabalin—Pollakiuria—Doxorubicin—kidney cancer	0.000109	0.000121	CcSEcCtD
Pregabalin—Asthenia—Gemcitabine—kidney cancer	0.000108	0.000121	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—CYP1A1—kidney cancer	0.000108	0.0014	CbGpPWpGaD
Pregabalin—Chest pain—Capecitabine—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Arthralgia—Capecitabine—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Myalgia—Capecitabine—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Pain—Paclitaxel—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Constipation—Paclitaxel—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Anxiety—Capecitabine—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000108	0.00012	CcSEcCtD
Pregabalin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000107	0.00012	CcSEcCtD
Pregabalin—Weight increased—Doxorubicin—kidney cancer	0.000107	0.000119	CcSEcCtD
Pregabalin—Discomfort—Capecitabine—kidney cancer	0.000107	0.000119	CcSEcCtD
Pregabalin—Pruritus—Gemcitabine—kidney cancer	0.000107	0.000119	CcSEcCtD
Pregabalin—Weight decreased—Doxorubicin—kidney cancer	0.000106	0.000118	CcSEcCtD
Pregabalin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000106	0.000118	CcSEcCtD
Pregabalin—Dry mouth—Capecitabine—kidney cancer	0.000106	0.000118	CcSEcCtD
Pregabalin—Nausea—Dactinomycin—kidney cancer	0.000106	0.000118	CcSEcCtD
Pregabalin—Pneumonia—Doxorubicin—kidney cancer	0.000106	0.000117	CcSEcCtD
Pregabalin—Dizziness—Vincristine—kidney cancer	0.000105	0.000117	CcSEcCtD
Pregabalin—Infestation NOS—Doxorubicin—kidney cancer	0.000105	0.000117	CcSEcCtD
Pregabalin—Infestation—Doxorubicin—kidney cancer	0.000105	0.000117	CcSEcCtD
Pregabalin—Confusional state—Capecitabine—kidney cancer	0.000105	0.000116	CcSEcCtD
Pregabalin—Feeling abnormal—Paclitaxel—kidney cancer	0.000104	0.000116	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GSTP1—kidney cancer	0.000104	0.00135	CbGpPWpGaD
Pregabalin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000104	0.000116	CcSEcCtD
Pregabalin—Oedema—Capecitabine—kidney cancer	0.000104	0.000116	CcSEcCtD
Pregabalin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000103	0.000115	CcSEcCtD
Pregabalin—Diarrhoea—Gemcitabine—kidney cancer	0.000103	0.000115	CcSEcCtD
Pregabalin—Renal failure—Doxorubicin—kidney cancer	0.000103	0.000115	CcSEcCtD
Pregabalin—Infection—Capecitabine—kidney cancer	0.000103	0.000115	CcSEcCtD
Pregabalin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000103	0.000114	CcSEcCtD
Pregabalin—Stomatitis—Doxorubicin—kidney cancer	0.000102	0.000114	CcSEcCtD
Pregabalin—Jaundice—Doxorubicin—kidney cancer	0.000102	0.000114	CcSEcCtD
Pregabalin—Shock—Capecitabine—kidney cancer	0.000102	0.000114	CcSEcCtD
Pregabalin—Urinary tract infection—Doxorubicin—kidney cancer	0.000102	0.000113	CcSEcCtD
Pregabalin—Conjunctivitis—Doxorubicin—kidney cancer	0.000102	0.000113	CcSEcCtD
Pregabalin—Nervous system disorder—Capecitabine—kidney cancer	0.000102	0.000113	CcSEcCtD
Pregabalin—Thrombocytopenia—Capecitabine—kidney cancer	0.000102	0.000113	CcSEcCtD
Pregabalin—Tachycardia—Capecitabine—kidney cancer	0.000101	0.000113	CcSEcCtD
Pregabalin—Vomiting—Vincristine—kidney cancer	0.000101	0.000113	CcSEcCtD
Pregabalin—Skin disorder—Capecitabine—kidney cancer	0.000101	0.000112	CcSEcCtD
Pregabalin—Sweating—Doxorubicin—kidney cancer	0.000101	0.000112	CcSEcCtD
Pregabalin—Urticaria—Paclitaxel—kidney cancer	0.0001	0.000112	CcSEcCtD
Pregabalin—Rash—Vincristine—kidney cancer	0.0001	0.000112	CcSEcCtD
Pregabalin—Hyperhidrosis—Capecitabine—kidney cancer	0.0001	0.000112	CcSEcCtD
Pregabalin—Dermatitis—Vincristine—kidney cancer	0.0001	0.000112	CcSEcCtD
Pregabalin—Haematuria—Doxorubicin—kidney cancer	0.0001	0.000111	CcSEcCtD
Pregabalin—Body temperature increased—Paclitaxel—kidney cancer	0.0001	0.000111	CcSEcCtD
Pregabalin—Abdominal pain—Paclitaxel—kidney cancer	0.0001	0.000111	CcSEcCtD
Pregabalin—Headache—Vincristine—kidney cancer	9.98e-05	0.000111	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—kidney cancer	9.89e-05	0.00011	CcSEcCtD
Pregabalin—Anorexia—Capecitabine—kidney cancer	9.89e-05	0.00011	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—ABCB1—kidney cancer	9.86e-05	0.00128	CbGpPWpGaD
Pregabalin—Sinusitis—Doxorubicin—kidney cancer	9.84e-05	0.00011	CcSEcCtD
Pregabalin—Hypotension—Capecitabine—kidney cancer	9.7e-05	0.000108	CcSEcCtD
Pregabalin—Vomiting—Gemcitabine—kidney cancer	9.6e-05	0.000107	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—kidney cancer	9.59e-05	0.000107	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GSTM1—kidney cancer	9.58e-05	0.00124	CbGpPWpGaD
Pregabalin—Rash—Gemcitabine—kidney cancer	9.52e-05	0.000106	CcSEcCtD
Pregabalin—Dermatitis—Gemcitabine—kidney cancer	9.52e-05	0.000106	CcSEcCtD
Pregabalin—Haemoglobin—Doxorubicin—kidney cancer	9.46e-05	0.000105	CcSEcCtD
Pregabalin—Headache—Gemcitabine—kidney cancer	9.46e-05	0.000105	CcSEcCtD
Pregabalin—Nausea—Vincristine—kidney cancer	9.46e-05	0.000105	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.46e-05	0.000105	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—kidney cancer	9.44e-05	0.000105	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—kidney cancer	9.42e-05	0.000105	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—kidney cancer	9.42e-05	0.000105	CcSEcCtD
Pregabalin—Insomnia—Capecitabine—kidney cancer	9.39e-05	0.000104	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—kidney cancer	9.37e-05	0.000104	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—kidney cancer	9.35e-05	0.000104	CcSEcCtD
Pregabalin—Paraesthesia—Capecitabine—kidney cancer	9.32e-05	0.000104	CcSEcCtD
Pregabalin—Hypersensitivity—Paclitaxel—kidney cancer	9.32e-05	0.000104	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—kidney cancer	9.3e-05	0.000103	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—kidney cancer	9.28e-05	0.000103	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—kidney cancer	9.25e-05	0.000103	CcSEcCtD
Pregabalin—Dyspnoea—Capecitabine—kidney cancer	9.25e-05	0.000103	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—kidney cancer	9.23e-05	0.000103	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—CYP1A1—kidney cancer	9.08e-05	0.00118	CbGpPWpGaD
Pregabalin—Visual impairment—Doxorubicin—kidney cancer	9.07e-05	0.000101	CcSEcCtD
Pregabalin—Asthenia—Paclitaxel—kidney cancer	9.07e-05	0.000101	CcSEcCtD
Pregabalin—Decreased appetite—Capecitabine—kidney cancer	9.02e-05	0.0001	CcSEcCtD
Pregabalin—Nausea—Gemcitabine—kidney cancer	8.97e-05	9.99e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Capecitabine—kidney cancer	8.96e-05	9.97e-05	CcSEcCtD
Pregabalin—Fatigue—Capecitabine—kidney cancer	8.95e-05	9.96e-05	CcSEcCtD
Pregabalin—Pruritus—Paclitaxel—kidney cancer	8.95e-05	9.96e-05	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—kidney cancer	8.9e-05	9.91e-05	CcSEcCtD
Pregabalin—Pain—Capecitabine—kidney cancer	8.88e-05	9.88e-05	CcSEcCtD
Pregabalin—Constipation—Capecitabine—kidney cancer	8.88e-05	9.88e-05	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—kidney cancer	8.8e-05	9.79e-05	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—kidney cancer	8.78e-05	9.77e-05	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—kidney cancer	8.74e-05	9.73e-05	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—kidney cancer	8.74e-05	9.73e-05	CcSEcCtD
Pregabalin—Diarrhoea—Paclitaxel—kidney cancer	8.65e-05	9.63e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Capecitabine—kidney cancer	8.55e-05	9.52e-05	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—kidney cancer	8.54e-05	9.51e-05	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—kidney cancer	8.51e-05	9.47e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Capecitabine—kidney cancer	8.49e-05	9.45e-05	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—kidney cancer	8.49e-05	9.44e-05	CcSEcCtD
Pregabalin—Chills—Doxorubicin—kidney cancer	8.45e-05	9.4e-05	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—kidney cancer	8.41e-05	9.36e-05	CcSEcCtD
Pregabalin—Dizziness—Paclitaxel—kidney cancer	8.36e-05	9.31e-05	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—kidney cancer	8.32e-05	9.26e-05	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—kidney cancer	8.25e-05	9.18e-05	CcSEcCtD
Pregabalin—Urticaria—Capecitabine—kidney cancer	8.24e-05	9.18e-05	CcSEcCtD
Pregabalin—Abdominal pain—Capecitabine—kidney cancer	8.2e-05	9.13e-05	CcSEcCtD
Pregabalin—Body temperature increased—Capecitabine—kidney cancer	8.2e-05	9.13e-05	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—kidney cancer	8.2e-05	9.12e-05	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—kidney cancer	8.08e-05	8.99e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—POMC—kidney cancer	8.08e-05	0.00105	CbGpPWpGaD
Pregabalin—Tension—Doxorubicin—kidney cancer	8.04e-05	8.95e-05	CcSEcCtD
Pregabalin—Vomiting—Paclitaxel—kidney cancer	8.04e-05	8.95e-05	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—kidney cancer	8.03e-05	8.93e-05	CcSEcCtD
Pregabalin—Rash—Paclitaxel—kidney cancer	7.97e-05	8.87e-05	CcSEcCtD
Pregabalin—Dermatitis—Paclitaxel—kidney cancer	7.97e-05	8.87e-05	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—kidney cancer	7.96e-05	8.86e-05	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—kidney cancer	7.93e-05	8.82e-05	CcSEcCtD
Pregabalin—Headache—Paclitaxel—kidney cancer	7.92e-05	8.82e-05	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—kidney cancer	7.88e-05	8.77e-05	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—kidney cancer	7.73e-05	8.6e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Capecitabine—kidney cancer	7.65e-05	8.51e-05	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—kidney cancer	7.61e-05	8.46e-05	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—kidney cancer	7.58e-05	8.43e-05	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—kidney cancer	7.53e-05	8.38e-05	CcSEcCtD
Pregabalin—Nausea—Paclitaxel—kidney cancer	7.51e-05	8.36e-05	CcSEcCtD
Pregabalin—Asthenia—Capecitabine—kidney cancer	7.45e-05	8.29e-05	CcSEcCtD
Pregabalin—Malaise—Doxorubicin—kidney cancer	7.39e-05	8.23e-05	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—kidney cancer	7.36e-05	8.2e-05	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—kidney cancer	7.35e-05	8.18e-05	CcSEcCtD
Pregabalin—Pruritus—Capecitabine—kidney cancer	7.34e-05	8.17e-05	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—kidney cancer	7.34e-05	8.17e-05	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—kidney cancer	7.24e-05	8.06e-05	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—kidney cancer	7.2e-05	8.02e-05	CcSEcCtD
Pregabalin—Cough—Doxorubicin—kidney cancer	7.15e-05	7.96e-05	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—kidney cancer	7.1e-05	7.9e-05	CcSEcCtD
Pregabalin—Diarrhoea—Capecitabine—kidney cancer	7.1e-05	7.9e-05	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—kidney cancer	7.08e-05	7.88e-05	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—kidney cancer	6.98e-05	7.77e-05	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—kidney cancer	6.98e-05	7.77e-05	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—kidney cancer	6.98e-05	7.77e-05	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—kidney cancer	6.95e-05	7.74e-05	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.93e-05	7.71e-05	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—kidney cancer	6.9e-05	7.67e-05	CcSEcCtD
Pregabalin—Dizziness—Capecitabine—kidney cancer	6.86e-05	7.64e-05	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—kidney cancer	6.83e-05	7.6e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—POMC—kidney cancer	6.77e-05	0.000877	CbGpPWpGaD
Pregabalin—Confusional state—Doxorubicin—kidney cancer	6.75e-05	7.51e-05	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—kidney cancer	6.69e-05	7.45e-05	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—kidney cancer	6.69e-05	7.45e-05	CcSEcCtD
Pregabalin—Infection—Doxorubicin—kidney cancer	6.65e-05	7.4e-05	CcSEcCtD
Pregabalin—Vomiting—Capecitabine—kidney cancer	6.6e-05	7.34e-05	CcSEcCtD
Pregabalin—Shock—Doxorubicin—kidney cancer	6.58e-05	7.33e-05	CcSEcCtD
Pregabalin—Nervous system disorder—Doxorubicin—kidney cancer	6.56e-05	7.3e-05	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—kidney cancer	6.55e-05	7.29e-05	CcSEcCtD
Pregabalin—Rash—Capecitabine—kidney cancer	6.54e-05	7.28e-05	CcSEcCtD
Pregabalin—Dermatitis—Capecitabine—kidney cancer	6.54e-05	7.28e-05	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—kidney cancer	6.53e-05	7.27e-05	CcSEcCtD
Pregabalin—Headache—Capecitabine—kidney cancer	6.5e-05	7.24e-05	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—kidney cancer	6.5e-05	7.23e-05	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—kidney cancer	6.47e-05	7.2e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PTGS2—kidney cancer	6.44e-05	0.000834	CbGpPWpGaD
Pregabalin—Anorexia—Doxorubicin—kidney cancer	6.38e-05	7.1e-05	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—kidney cancer	6.25e-05	6.96e-05	CcSEcCtD
Pregabalin—Nausea—Capecitabine—kidney cancer	6.16e-05	6.86e-05	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.1e-05	6.78e-05	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—kidney cancer	6.05e-05	6.73e-05	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—kidney cancer	6.01e-05	6.69e-05	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—kidney cancer	5.96e-05	6.64e-05	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—kidney cancer	5.95e-05	6.62e-05	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—kidney cancer	5.82e-05	6.47e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.78e-05	6.43e-05	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—kidney cancer	5.77e-05	6.42e-05	CcSEcCtD
Pregabalin—Pain—Doxorubicin—kidney cancer	5.72e-05	6.37e-05	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—kidney cancer	5.72e-05	6.37e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PTEN—kidney cancer	5.62e-05	0.000728	CbGpPWpGaD
Pregabalin—Feeling abnormal—Doxorubicin—kidney cancer	5.51e-05	6.14e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.47e-05	6.09e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PTGS2—kidney cancer	5.4e-05	0.000699	CbGpPWpGaD
Pregabalin—Urticaria—Doxorubicin—kidney cancer	5.31e-05	5.91e-05	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—kidney cancer	5.29e-05	5.89e-05	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—kidney cancer	5.29e-05	5.89e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—kidney cancer	4.93e-05	5.49e-05	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—kidney cancer	4.8e-05	5.34e-05	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—kidney cancer	4.73e-05	5.27e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PTEN—kidney cancer	4.71e-05	0.00061	CbGpPWpGaD
Pregabalin—Diarrhoea—Doxorubicin—kidney cancer	4.58e-05	5.09e-05	CcSEcCtD
Pregabalin—Dizziness—Doxorubicin—kidney cancer	4.42e-05	4.92e-05	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—kidney cancer	4.25e-05	4.73e-05	CcSEcCtD
Pregabalin—Rash—Doxorubicin—kidney cancer	4.22e-05	4.69e-05	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—kidney cancer	4.21e-05	4.69e-05	CcSEcCtD
Pregabalin—Headache—Doxorubicin—kidney cancer	4.19e-05	4.66e-05	CcSEcCtD
Pregabalin—Nausea—Doxorubicin—kidney cancer	3.97e-05	4.42e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PIK3CA—kidney cancer	3.96e-05	0.000513	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CA—kidney cancer	3.32e-05	0.00043	CbGpPWpGaD
